Leucovorin

Leucovorin

SCHEMBL9054183

Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O.[SrH2]

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.78
LMNA P02545 1/20 0.61
MTHFD1 P11586 3/20 0.57
SOST Q9BQB4 1/20 0.57
MTHFD2 P13995 3/20 0.51
FPGS Q05932 2/20 0.51
ATIC P31939 2/20 0.50
TYMS P04818 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
AKR1B1 P15121 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
PTGS2 P35354 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leucovorin SCHEMBL21632556 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Levoleucovorin SCHEMBL571901 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL5132046 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL8349 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL8350 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL4708750 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL571902 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Folinic Acid SCHEMBL29369091 0.99 DHFR (0.80) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL9054117 0.98 DHFR (0.78) DHFRLMNAMTHFD1SOSTMTHFD2
Leucovorin SCHEMBL16207660 0.98 DHFR (0.78) DHFRLMNAMTHFD1SOSTMTHFD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0432441-B1 Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds AMERICAN CYANAMID CO (US) 1996-06-26 EP disclosed
EP-0416232-B1 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method AMERICAN CYANAMID CO (US) 1995-08-16 EP disclosed
US-5334535-A Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds using 10-formyltetrahydrofolate synthetase from clostridium AMERICAN CYANAMID COMPANY (US) 1994-08-02 US disclosed
US-5173488-A Tromethamine and monothioglycerol as buffers and antioxidants AMERICAN CYANAMID COMPANY (US) 1992-12-22 US disclosed
EP-0432441-A1 Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds AMERICAN CYANAMID COMPANY (US) 1991-06-19 EP disclosed
EP-0416232-A2 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method AMERICAN CYANAMID COMPANY (US) 1991-03-13 EP disclosed